New blood pressure drug enters first human tests

NCT ID NCT06823947

First seen Mar 10, 2026 · Last updated May 23, 2026 · Updated 12 times

Summary

This early-stage study tests a new medicine called KK3910 in healthy volunteers and people with high blood pressure. The main goal is to check safety and how the drug moves through the body. About 160 Japanese participants will take either the drug or a placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS ESSENTIAL HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Kitasato University Kitasato Institute Hospital

    RECRUITING

    Minato-ku, Tokyo, 108-8642, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Medical Corporation Heishinkai OPHAC Hospital

    NOT_YET_RECRUITING

    Yodogawa, Osaka, 532-0003, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • SOUSEIKAI PS Clinic

    NOT_YET_RECRUITING

    Hakata, Fukuoka, 812-0025, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.